Cargando…
Surprises in cardiology: efficacy of gliflozines in heart failure even in the absence of diabetes
It is now well-established that the therapy of type II diabetes mellitus has undergone a radical change in the past 15 years: countless innovative drugs, such as SGLT2I, able to guarantee an optimization of glycaemic control without causing hypoglycaemia, today represent real therapeutic cornerstone...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503418/ https://www.ncbi.nlm.nih.gov/pubmed/34650352 http://dx.doi.org/10.1093/eurheartj/suab094 |